infect
weanl
mice
te
strain
sindbi
viru
sinv
caus
nonfat
encephalomyel
associ
hippocampalbas
memori
impair
partial
prevent
treatment
glutamin
antagonist
potter
et
al
j
neurovirol
determin
mechan
protect
lymph
node
central
nervou
system
cn
tissu
sinvinfect
mice
treat
daili
week
low
mgkg
high
mgkg
dose
examin
treatment
suppress
lymphocyt
prolifer
cervic
lymph
node
result
reduc
cn
immun
cell
infiltr
inflamm
cell
death
compar
untreat
sinvinfect
mice
product
sinvspecif
antibodi
interferongamma
also
impair
treatment
delay
viru
clearanc
cessat
treatment
allow
activ
antivir
immun
respons
viral
clearanc
reviv
cn
patholog
demonstr
abil
immun
respons
mediat
cn
damag
viru
clearanc
recent
epidem
rash
arthriti
encephalomyel
emphas
import
arthropodborn
virus
primarili
alphavirus
flavivirus
threaten
public
health
lubelczyk
et
al
molaei
et
al
weaver
et
al
encephalomyel
induc
infect
alphavirus
sever
outcom
depend
viru
speci
babi
et
al
baig
et
al
bruyn
lennett
ethier
rogg
harvala
et
al
luri
castillo
mancao
et
al
przelomski
et
al
reddi
et
al
riva
et
al
rozdilski
et
al
schultz
et
al
vilcarromero
et
al
eastern
equin
enceph
viru
neurovirul
fatal
commonli
infant
children
frequent
neurolog
sequela
surviv
deresiewicz
et
al
finley
et
al
current
treatment
beyond
support
care
avail
licens
vaccin
alphaviru
encephalomyel
approv
nonmilitari
human
use
need
identifi
new
approach
treatment
go
et
al
infect
mice
sindbi
viru
sinv
lead
encephalomyel
provid
model
evalu
clinic
diseas
central
nervou
system
cn
patholog
induc
alphaviru
infect
sinv
preferenti
infect
neuron
mice
particularli
hippocamp
neuron
brain
motor
neuron
spinal
cord
outcom
depend
strain
infect
viru
genet
background
mous
kimura
griffin
griffin
weanl
mice
infect
neurovirul
nsv
strain
sinv
develop
fatal
encephalomyel
mice
infect
less
virul
te
strain
recov
persist
hippocampaldepend
memori
deficit
measur
fear
condit
potter
et
al
immun
respons
alphaviru
infect
cn
present
doubleedg
sword
immun
respons
necessari
bring
viru
replic
product
control
also
respons
mani
patholog
chang
neurolog
damag
produc
infect
neurovirul
nsv
strain
sinv
fatal
encephalomyel
coincid
infiltr
cell
brain
kulcsar
et
al
studi
mice
lack
compon
immun
respons
particularli
cell
deficit
mortal
sever
diseas
decreas
rowel
griffin
kimura
griffin
furthermor
previou
studi
shown
inhibit
immun
respons
glutam
excitotox
proprano
acid
ampa
receptor
antagonist
protect
nsvinfect
mice
fatal
encephalomyel
green
et
al
nargiaizenman
et
al
diazocontain
glutamin
analog
act
broad
irrevers
competit
inhibitor
sever
glutamineutil
enzym
thangavelu
et
al
growth
prolifer
cell
preferenti
use
glutamin
instead
glucos
energi
sourc
rapidli
divid
activ
cell
show
increas
glutamin
uptak
metabol
maciolek
et
al
therefor
glutamin
antagon
inhibit
lymphocyt
prolifer
wang
et
al
cn
excitatori
neurotransmitt
glutam
synthes
glutamin
amidohydrolas
enzym
glutaminas
excess
product
glutam
lead
neuron
death
glutam
excitotox
inhibit
glutaminas
via
might
abrog
process
sattler
tymianski
support
approach
mice
infect
fatal
nsv
strain
sinv
show
reduc
mortal
treatment
manivannan
et
al
less
virul
te
strain
sinv
reduc
develop
clinic
diseas
hippocampusdepend
memori
deficit
determin
mechan
improv
outcom
nonfat
alphaviru
encephalomyel
examin
effect
treatment
patholog
chang
viru
clearanc
cn
te
strain
sinv
lustig
et
al
grown
assay
plaqu
format
babi
hamster
kidney
bhk
cell
four
sixweekold
male
mice
jackson
laboratori
infect
intranas
pfu
sinv
pb
mockinfect
pb
light
isofluran
anesthesia
intraperiton
administ
day
day
infect
day
post
infect
dpi
dose
mgkg
low
dose
mgkg
high
dose
previous
describ
control
anim
receiv
volum
pb
studi
done
accord
protocol
approv
john
hopkin
univers
institut
anim
care
use
committe
two
time
point
drug
administr
dpi
two
time
point
follow
cessat
treatment
dpi
mice
euthan
isofluran
overdos
perfus
ml
ice
cold
pb
follow
blood
collect
cardiocentesi
blood
allow
coagul
bd
microtain
serum
separ
tube
centrifug
min
rcf
serum
collect
store
rna
plaqu
assay
analysi
brain
spinal
cord
collect
flashfrozen
store
histopatholog
immunohistochemistri
mice
perfus
ml
cold
paraformaldehyd
pfa
brain
spinal
column
collect
brain
divid
three
coron
section
use
adult
mous
brain
slicer
zivic
instrument
fix
overnight
pfa
wash
icecold
pb
spinal
column
trim
excess
soft
tissu
fix
overnight
pfa
decalcifi
rotat
h
sodium
formic
acid
solut
spinal
column
wash
icecold
pb
region
isol
tissu
embed
paraffin
section
stain
singl
cell
suspens
made
cervic
lymph
node
cln
brain
spinal
cord
pool
two
five
mice
per
group
per
time
point
previous
describ
briefli
cln
dissoci
use
gentlemac
dissoci
miltenyl
biotec
red
blood
cell
lyse
use
ammonium
chlorid
sigmaaldrich
brain
spinal
cord
dissoci
rpmi
contain
collagenas
dnase
c
tube
use
gentlemac
dissoci
mononuclear
cell
separ
red
blood
cell
myelin
debri
percol
gradient
ge
healthcar
min
live
mononuclear
cell
tissu
quantifi
trypan
blue
exclus
cell
stain
analyz
flow
cytometri
previous
describ
briefli
live
cell
stain
violet
livedead
fixabl
dead
cell
stain
life
technolog
min
antimous
bd
pharmingen
min
monoclon
antibodi
clone
clone
clone
clone
clone
ebiosci
bd
pharmingen
min
cell
run
bd
facscanto
ii
cytomet
use
bd
facsdiva
softwar
version
analys
carri
use
flowjo
softwar
version
cell
character
follow
cell
hi
cell
hi
b
cell
hi
cln
brain
total
mononuclear
cell
count
three
independ
experi
spinal
cord
well
cell
tissu
count
two
independ
experi
dpi
sinv
mgkg
group
data
one
fewer
experi
other
one
two
independ
experi
three
four
brain
section
per
mous
stain
h
e
code
score
previous
describ
rowel
griffin
use
scale
score
given
detect
inflamm
score
brain
one
two
small
inflammatori
foci
per
section
score
moder
inflammatori
foci
field
score
moder
larg
inflammatori
foci
greater
field
addit
point
ad
excess
parenchym
cellular
allow
maxim
score
three
four
lumbar
spinal
cord
section
per
mous
stain
h
e
code
score
use
scale
adapt
brain
score
system
score
given
detect
inflamm
score
one
two
small
inflammatori
foci
per
section
score
greater
two
inflammatori
foci
per
spinal
cord
spinal
cord
moder
mark
inflammatori
foci
addit
point
ad
excess
parenchym
cellular
allow
maxim
score
immunohistochem
stain
brain
section
deparaffin
hydrat
antigen
retriev
perform
boil
slide
sodium
citrat
ph
glial
fibrillari
acid
protein
gfap
endogen
peroxidas
quench
h
methanol
min
ioniz
calcium
bind
adaptor
molecul
glutam
transport
slide
block
normal
goat
serum
ng
incub
primari
antibodi
dilut
pb
ng
tritonx
gfap
millipor
h
rt
wako
overnight
rothstein
et
al
overnight
tissu
stain
gfap
addit
treat
avidinbiotin
block
kit
vector
laboratori
prior
primari
antibodi
incub
tissu
incub
secondari
antirabbit
igg
vector
laboratori
pb
ng
triton
x
h
rt
vectastain
elit
abc
kit
vector
laboratori
visual
dab
peroxidas
substrat
vector
tissu
counterstain
hematoxylin
dehydr
mount
permount
fisher
scientif
tunel
stain
brain
spinal
cord
section
rehydr
treat
mgml
proteinas
k
deioniz
water
min
antigen
retriev
endogen
peroxidas
quench
methanol
h
min
immers
tdt
label
buffer
min
section
stain
tdt
label
reaction
mix
min
humid
chamber
stop
reaction
slide
immers
tdt
stop
buffer
min
incub
streptavidinhrp
solut
min
tac
tdt
kit
trevigen
tissu
develop
dab
min
counterstain
hematoxylin
dehydr
mount
permount
slide
code
whole
visibl
hippocampu
one
brain
section
per
mous
entir
spinal
cord
cross
section
outlin
determin
tissu
area
use
nikon
eclips
microscop
stereoinvestig
softwar
mbf
bioscienc
tunelposit
cell
indic
brown
stain
count
within
outlin
area
result
graph
tunelposit
cell
per
mm
tissu
sinv
antigen
stain
brain
spinal
cord
section
rehydr
treat
mgml
proteinas
k
invitrogen
min
antigen
retriev
endogen
peroxid
quench
methanol
h
min
tissu
block
ng
pb
min
slide
incub
rabbit
antisera
sinv
pb
ng
tritonx
min
biotinyl
antirabbit
igg
secondari
antibodi
pb
ng
tritonx
min
avidinbiotin
complex
vectastain
elit
abc
kit
min
slide
develop
dab
counterstain
mount
protein
quantifi
wv
whole
brain
homogen
two
independ
experi
two
individu
mice
per
group
experi
total
four
mice
per
group
use
dc
assay
kit
bio
rad
laboratori
sampl
separ
sdspage
gel
transfer
nitrocellulos
membran
bio
rad
confirm
protein
presenc
use
ponceau
stain
sigma
aldrich
membran
block
milk
membran
incub
overnight
antigfap
millipor
wako
chemic
laboratori
rothstein
et
al
dilut
bsa
membran
incub
hrpconjug
secondari
antirabbit
igg
cell
signal
dilut
milk
antigfap
respect
h
rt
membran
develop
use
amersham
ecl
prime
western
blot
develop
kit
ge
healthcar
membran
expos
either
darkroom
amersham
hyperfilm
eclhigh
perform
chemiluminesc
film
gfap
associ
actb
use
biorad
univers
hood
ii
chemidoc
xr
imag
camera
associ
actb
densitometri
measur
perform
use
imagej
softwar
averag
foldchang
protein
normal
actb
compar
mockinfect
untreat
control
homogen
calcul
antisinv
antibodi
measur
serum
wv
brain
homogen
three
four
mice
per
group
per
time
point
use
inhous
enzym
immunoassay
eia
previous
describ
briefli
maxisorp
plate
thermo
scientif
nunc
coat
pegpurifi
sinv
te
block
fb
h
incub
overnight
sampl
igm
igg
serum
brain
homogen
dilut
fb
incub
well
hrpconjug
goat
antimous
igm
igg
southern
biotech
h
rt
plate
develop
use
bd
opteia
tmb
substrat
reagent
kit
stop
use
h
plate
read
nm
optic
densiti
od
valu
infect
mice
minu
od
valu
mockinfect
mice
graph
interferongamma
product
quantifi
wv
brain
homogen
mice
per
group
per
time
point
commerci
eia
kit
ebiosci
readysetgo
assay
perform
accord
manufactur
instruct
data
present
pg
per
gram
brain
standard
curv
assay
rang
pgg
icecold
pb
ad
left
halv
brain
wv
whole
spinal
cord
wv
previous
frozen
store
mice
per
group
per
time
point
tissu
homogen
mp
biomed
lyse
matrix
tube
ms
use
homogen
mp
biomed
clarifi
centrifug
rpm
min
supernat
fluid
serial
dilut
tenfold
dmem
fb
incub
bhk
cell
h
agaros
overlay
appli
assay
plate
incub
co
h
plaqu
count
use
neutral
red
solut
stain
live
cell
aid
visual
sampl
detect
plaqu
valu
half
limit
detect
assay
assign
qrtpcr
evalu
mrna
express
viral
rna
product
right
brain
halv
whole
spinal
cord
three
five
mice
per
group
per
time
point
place
lyse
matrix
tube
homogen
ml
qiazol
ms
homogen
mp
biomed
rna
isol
use
qiagen
rneasi
lipid
mini
kit
cdna
synthes
random
primer
use
life
technolog
high
capac
cdna
revers
transcript
kit
qrtpcr
perform
use
taqman
univers
pcr
master
mix
roch
fast
realtim
pcr
system
cycl
result
analyz
use
sequenc
detector
softwar
version
ifng
mrna
measur
use
commerci
avail
taqman
gene
express
assay
integr
dna
technolog
rel
gene
express
versu
mockinfect
mice
determin
method
use
mous
gapdh
normal
sinv
rna
copi
measur
use
taqman
probe
fam
tamra
appli
biosystem
primer
sinv
gene
forward
revers
sinv
copi
quantifi
use
standard
curv
made
tenfold
dilut
plasmid
contain
sinv
subgenom
region
normal
endogen
mous
gapdh
statist
analys
perform
use
graphpad
prism
softwar
timecours
studi
analyz
twoway
anova
tukey
multipl
comparison
posttest
singl
time
point
studi
analyz
oneway
anova
tukey
multipl
comparison
posttest
p
valu
consid
signific
analys
vk
baxter
et
al
virolog
result
determin
effect
treatment
begin
time
infect
induct
immun
respons
peripheri
entri
immun
cell
cn
drain
cervic
lymph
node
cln
cn
tissu
examin
mice
infect
intranas
te
strain
sinv
lymphocyt
prolifer
respons
antigen
stimul
requir
util
glutamin
energi
sourc
maciolek
et
al
hypothes
treatment
would
reduc
product
sinvspecif
lymphocyt
infiltr
immun
cell
cn
sinv
infect
examin
effect
daili
low
mgkg
high
mgkg
dose
cellular
immun
respons
infect
chang
number
total
cell
cell
b
cell
evalu
cln
brain
spinal
cord
sinvinfect
mice
treatment
dpi
cessat
treatment
dpi
fig
mononuclear
cell
isol
tissu
homogen
total
live
cell
count
low
mgkg
dose
high
mgkg
dose
dpi
n
pool
mice
per
group
per
time
point
independ
experi
except
sinv
mgkg
group
dpi
independ
experi
data
present
mean
sem
doublehead
arrow
indic
period
treatment
p
p
p
p
tukey
multipl
comparison
test
vk
baxter
et
al
virolog
fig
number
cell
fig
cell
fig
b
cell
fig
determin
flow
cytometri
cln
cell
type
increas
untreat
sinvinfect
mice
highest
number
total
mononuclear
cell
cell
cell
dpi
highest
number
b
cell
dpi
dontreat
sinvinfect
mice
cln
cell
number
begin
increas
dpi
mice
receiv
low
dose
increas
period
observ
mice
receiv
high
dose
brain
spinal
cord
untreat
sinvinfect
mice
total
number
mononuclear
cell
increas
start
dpi
peak
dpi
tissu
cell
popul
steadili
increas
number
peak
dpi
dontreat
sinvinfect
mice
evid
infiltr
cell
popul
brain
spinal
cord
day
treatment
howev
cessat
treatment
total
mononuclear
cell
b
cell
increas
dpi
cell
evid
brain
dpi
mice
treat
low
dose
similar
increas
infiltr
cell
spinal
cord
dontreat
mice
seen
time
taken
togeth
data
indic
treatment
inhibit
prolifer
b
cell
peripheri
respons
sinv
infect
result
decreas
infiltr
immun
cell
cn
cessat
treatment
immun
respons
gradual
activ
examin
effect
glutamin
antagon
cn
patholog
sinv
infect
coron
brain
section
fig
transvers
lumbar
spinal
cord
fig
section
sinvinfect
mice
untreat
treat
low
high
dose
stain
h
e
evalu
patholog
chang
evid
inflamm
inflamm
patholog
chang
present
throughout
brain
hippocampu
chosen
closer
evalu
due
predilect
sinv
neuron
kimura
griffin
hippocampi
spinal
cord
untreat
sinvinfect
mice
perivascular
cuff
mononuclear
cell
increas
parenchym
cellular
appreci
dpi
fig
dpi
disrupt
neuron
architectur
hippocampu
multifoc
area
granul
cell
loss
immun
cell
infiltr
dentat
gyru
fig
dpi
tissu
necrosi
note
later
ventral
horn
spinal
cord
fig
increas
inflamm
patholog
chang
resolv
dpi
compar
mockinfect
control
data
shown
evid
increas
inflamm
patholog
chang
brain
spinal
cord
sinvinfect
mice
treat
low
high
dose
period
drug
administr
follow
cessat
treatment
perivascular
cuff
mononuclear
cell
becam
appar
dpi
hippocampi
spinal
cord
sinvinfect
mice
previous
treat
disrupt
normal
architectur
granul
layer
dentat
gyru
note
dpi
sinvinfect
mice
previous
treat
low
dose
quantifi
level
inflamm
h
estain
slide
code
score
rowel
griffin
brain
inflamm
score
significantli
differ
among
group
fig
p
twoway
anova
untreat
sinvinfect
mice
higher
score
sinvinfect
low
dose
dontreat
mice
dpi
sinvinfect
high
dose
dontreat
mice
dpi
inflamm
score
began
decreas
dpi
untreat
mice
start
dpi
follow
cessat
treatment
brain
inflamm
score
sinvinfect
low
dose
dontreat
mice
began
increas
becom
significantli
higher
sinvinfect
high
dose
dontreat
mice
dpi
significantli
higher
untreat
sinvinfect
mice
dpi
inflamm
score
sinvinfect
high
dose
dontreat
mous
brain
began
increas
dpi
lumbar
spinal
cord
score
inflamm
show
trend
similar
brain
fig
inflamm
score
differ
significantli
among
group
p
twoway
anova
score
untreat
sinvinfect
mice
significantli
higher
sinvinfect
low
dose
dontreat
mice
dpi
significantli
higher
sinvinfect
high
dose
dontreat
mice
dpi
follow
cessat
treatment
inflamm
score
began
increas
sinvinfect
low
dose
dontreat
sinvinfect
high
dose
dontreat
mice
dpi
respect
dpi
spinal
cord
inflamm
score
compar
among
treatment
group
data
show
glutamin
antagon
suppress
inflamm
cn
patholog
chang
due
sinv
infect
treatment
cessat
treatment
result
appear
inflamm
time
dosedepend
manner
mechan
like
contribut
neuron
damag
alphaviru
infect
glutam
excitotox
accompani
glial
cell
activ
darman
et
al
green
et
al
nargiaizenman
et
al
evalu
potenti
role
treatment
mitig
glutam
excitotox
sinv
infect
glial
cell
marker
associ
glutam
excitotox
viru
infect
examin
brison
et
al
darman
et
al
express
gfap
astrocyt
microgli
cell
assess
immunohistochemistri
ihc
immunoblot
maxim
chanc
observ
effect
marker
examin
dpi
period
treatment
gfap
intermedi
filament
protein
highli
express
activ
astrocyt
eng
ghirnikar
gfap
express
increas
sinv
infect
assess
ihc
immunoblot
fig
overal
level
protein
differ
among
group
fig
p
oneway
anova
affect
treatment
suggest
increas
gfap
direct
result
local
innat
respons
neuron
viru
infect
carpenti
et
al
also
known
astrocyt
transport
protein
respons
glutam
scaveng
within
cn
danbolt
control
brain
highli
express
widespread
stain
extraneuron
mileu
sinv
infect
express
hippocampu
variabl
area
devoid
ihc
stain
fig
overal
decreas
express
immunoblot
fig
dontreat
mice
distribut
ihc
restor
found
mockinfect
untreat
control
mice
protein
level
individu
mice
immunoblot
variabl
densiti
quantif
identifi
signific
differ
group
fig
cytoplasm
protein
specif
express
macrophag
microglia
upregul
cellular
activ
ito
et
al
sinv
infect
express
increas
ihc
immunoblot
compar
mockinfect
untreat
control
fig
f
p
oneway
anova
compar
brain
sinvinfect
untreat
mice
less
highli
express
brain
mice
treat
reduc
control
level
three
marker
treatment
appreci
impact
protein
express
brain
mockinfect
mice
ihc
data
shown
therefor
treatment
sinvinfect
mice
variabl
effect
marker
glial
cell
activ
associ
glutam
excitotox
death
neuron
viral
infect
result
signific
organ
dysfunct
evalu
whether
treatment
decreas
cell
death
vk
baxter
et
al
virolog
brain
spinal
cord
sinv
infect
coron
brain
section
transvers
lumbar
spinal
cord
section
sinvinfect
mice
treat
low
high
dose
examin
tunel
stain
increas
number
tunelposit
cell
present
dpi
hippocampi
sinvinfect
mice
fig
tunelposit
cell
rare
detect
hippocampi
sinvinfect
mice
treat
low
high
dose
period
treatment
increas
frequenc
within
granular
cell
layer
dentat
gyru
dpi
dpi
tunelposit
cell
rare
found
hippocampi
group
spinal
cord
section
sinvinfect
mice
tunelposit
cell
present
throughout
dpi
fewer
either
dpi
fig
tunelposit
cell
rare
present
spinal
cord
sinvinfect
mice
treat
low
high
dose
time
point
quantif
tunelposit
cell
show
untreat
sinvinfect
mice
cell
death
sinvinfect
low
high
dose
dontreat
mice
hippocampu
dpi
fig
spinal
cord
dpi
fig
evid
cell
death
compar
group
dpi
tissu
previou
studi
shown
clearanc
infecti
sinv
cn
affect
synergist
b
cellproduc
antibodi
direct
low
mgkg
dose
high
mgkg
dose
score
inflamm
dpi
use
threepoint
system
n
mice
per
group
per
time
point
data
present
mean
sem
doublehead
arrow
indic
period
treatment
p
p
tukey
multipl
comparison
test
vk
baxter
et
al
virolog
sinv
glycoprotein
cellproduc
binder
griffin
levin
et
al
glutamin
antagon
suppress
lymphocyt
prolifer
colombo
et
al
newsholm
et
al
wang
et
al
fig
antivir
effector
function
cell
evalu
follow
treatment
sinv
infect
level
sinvspecif
igm
igg
evalu
sera
brain
sinvinfect
dontreat
mice
eia
fig
serum
igm
fig
igg
fig
significantli
higher
untreat
mice
compar
low
high
dose
dontreat
mice
p
igm
p
igg
twoway
anova
time
f
express
examin
immunoblot
whole
brain
mockinfect
sinvinfect
mice
receiv
treatment
low
mgkg
dose
high
mgkg
dose
dpi
rel
whole
brain
express
actbnorm
gfap
g
h
quantifi
compar
mockinfect
control
brain
n
mice
per
group
combin
independ
experi
data
present
mean
sem
p
p
p
tukey
multipl
comparison
test
vk
baxter
et
al
virolog
point
igm
dpi
igg
antisinv
igm
igg
sera
low
high
dose
dontreat
mice
increas
follow
cessat
treatment
dpi
sinvspecif
brain
igm
fig
igg
fig
differ
among
treatment
group
p
igm
igg
twoway
anova
increas
delay
comparison
appear
antibodi
serum
brain
antisinv
antibodi
higher
untreat
mice
compar
low
high
dose
dontreat
mice
dpi
igm
dpi
igg
antisinv
igm
igg
increas
brain
low
dose
dontreat
high
dose
dontreat
mice
follow
cessat
treatment
result
show
glutamin
antagon
decreas
antisinv
antibodi
product
serum
brain
sinv
infect
cessat
treatment
allow
increas
product
vk
baxter
et
al
virolog
also
contribut
viru
clearanc
binder
griffin
effect
glutamin
antagon
express
brain
sinv
infect
cn
examin
measur
level
ifng
mrna
qrtpcr
level
protein
eia
overal
ifng
mrna
express
normal
untreat
mockinfect
mous
brain
significantli
differ
among
group
fig
p
twoway
anova
untreat
sinvinfect
mice
increas
express
dpi
compar
low
high
dose
dontreat
mice
ifng
mrna
express
brain
sinvinfect
low
high
dose
dontreat
mice
approxim
higher
untreatedmockinfect
mice
follow
cessat
treatment
ifng
express
increas
start
dpi
sinv
vk
baxter
et
al
virolog
infect
low
dose
dontreat
mice
increas
express
compar
untreat
sinvinfect
mice
dpi
ifng
express
mockinfect
high
dose
dontreat
mous
brain
compar
untreat
mockinfect
mous
brain
data
shown
protein
level
brain
significantli
differ
among
group
fig
p
twoway
anova
untreat
sinvinfect
mice
higher
express
dpi
compar
low
high
dose
dontreat
mice
follow
cessat
treatment
express
increas
start
dpi
sinvinfect
low
high
dose
dontreat
mice
significantli
increas
express
compar
untreat
sinvinfect
mice
dpi
level
level
detect
brain
mockinfect
mice
brain
sinvinfect
low
high
dose
dontreat
mice
period
drug
administr
dpi
data
show
glutamin
antagon
impair
two
major
adapt
antivir
respons
involv
clearanc
sinv
two
major
mechan
immun
respons
clear
sinv
cn
affect
glutamin
antagon
viru
product
examin
sinv
protein
visual
coron
brain
fig
lumbar
spinal
cord
fig
section
ihc
show
presenc
sinv
antigen
hippocampu
untreat
mice
dpi
fig
spinal
cord
dpi
fig
compar
level
sinv
antigen
stain
found
mice
treat
low
high
dose
tissu
addit
sinv
antigen
readili
visual
brain
spinal
cord
dontreat
untreat
mice
dpi
although
follow
cessat
administr
sinv
protein
began
decreas
dontreat
mice
treatment
affect
distribut
sinv
antigen
brain
spinal
cord
clearanc
infecti
viru
evalu
measur
viru
titer
plaqu
assay
clearanc
brain
delay
dontreat
mice
dosedepend
manner
titer
significantli
higher
dontreat
mice
dpi
fig
viru
titer
also
significantli
higher
spinal
cord
dontreat
mice
compar
untreat
mice
dpi
fig
viral
rna
clearanc
evalu
measur
viral
rna
level
qrtpcr
clearanc
delay
dontreat
mice
rna
copi
significantli
higher
untreat
mice
dpi
brain
fig
dpi
spinal
cord
fig
viral
rna
level
began
decreas
brain
dontreat
mice
follow
cessat
drug
administr
although
degre
infecti
viru
therefor
addit
suppress
immun
respons
sinv
infect
glutamin
antagon
delay
viru
clearanc
cn
brain
c
sinvinfect
mice
receiv
treatment
low
mgkg
dose
high
mgkg
dose
dpi
e
f
ifng
mrna
express
e
measur
rtqpcr
protein
level
f
measur
elisa
brain
sinvinfect
mice
receiv
treatment
low
mgkg
dose
high
mgkg
dose
dpi
n
mice
per
group
per
time
point
data
present
mean
sem
doublehead
arrow
indic
period
treatment
p
p
p
p
tukey
multipl
comparison
test
vk
baxter
et
al
virolog
discuss
studi
sought
determin
mechan
glutamin
antagon
protect
mice
neurolog
deficit
nonfat
alphaviru
encephalomyel
treatment
one
week
infect
impair
prolifer
lymphocyt
drain
cln
infiltr
mononuclear
cell
brain
spinal
cord
impair
immun
respons
result
decreas
patholog
chang
fewer
tunelposit
cell
cn
also
reduc
product
sinvspecif
antibodi
result
fig
effect
treatment
sinv
product
clearanc
brain
repres
photomicrograph
immunohistochem
stain
sinv
antigen
hippocampu
sinvinfect
mice
receiv
treatment
low
mgkg
dose
high
mgkg
dose
brain
dpi
sinv
antigen
brown
stain
magnif
scale
b
infecti
viru
titer
measur
plaqu
assay
brain
sinvinfect
mice
receiv
treatment
black
circl
line
low
dose
gray
squar
line
high
dose
white
diamond
black
line
c
viral
rna
level
measur
qrtpcr
brain
sinvinfect
mice
receiv
treatment
low
dose
high
dose
n
mice
per
group
per
time
point
data
present
mean
sem
doublehead
arrow
indic
period
treatment
dot
line
indic
assay
limit
detect
p
p
p
untreat
vs
low
dose
p
p
p
untreat
vs
high
dose
p
low
dose
vs
high
dose
tukey
multipl
comparison
test
vk
baxter
et
al
virolog
delay
viru
clearanc
affect
immun
respons
mostli
period
treatment
effect
cn
patholog
viru
clearanc
transient
upon
cessat
treatment
immun
respons
activ
cn
patholog
appear
viru
clearanc
initi
quickli
low
dosetr
high
dosetr
anim
variabl
effect
sinvinduc
glial
marker
glutam
excitotox
suggest
primari
mechan
decreas
patholog
modul
immun
respons
neuron
infect
viru
three
possibl
outcom
may
occur
griffin
first
viru
may
directli
kill
neuron
induc
process
apoptosi
necrosi
havert
et
al
vk
baxter
et
al
virolog
lewi
et
al
lewi
et
al
second
neuron
may
damag
die
secondari
process
effect
inflamm
glutam
excitotox
conradi
et
al
green
et
al
activ
nearbi
microglia
astrocyt
releas
reactiv
oxygen
nitrogen
speci
infiltr
monocyt
neutrophil
lymphocyt
releas
cytokin
may
facilit
neuron
damag
tilleux
herman
lastli
viru
infect
neuron
may
control
noncytolyt
immun
mechan
cell
surviv
sinv
rna
persist
infecti
viru
clear
immun
system
must
continu
control
viru
reactiv
previou
work
shown
fatal
alphaviru
encephalomyel
neuron
death
primarili
mediat
immun
respons
rather
direct
viral
mechan
green
et
al
kimura
griffin
treatment
suppress
inflamm
reduc
mortal
manivannan
et
al
likewis
nonfat
sinvinduc
encephalomyel
treatment
reduc
neurolog
sequela
howev
neither
studi
includ
indepth
examin
effect
treatment
develop
immun
respons
patholog
chang
cn
treatment
studi
show
neurolog
damag
includ
limit
neuron
death
nonfat
encephalomyel
immunemedi
rather
direct
effect
viru
replic
without
treatment
mononuclear
cell
begin
infiltr
brain
high
number
dpi
tunelposit
cell
peak
around
dpi
contrast
peak
infecti
viru
titer
occur
dpi
possibl
earlier
brain
despit
high
viru
titer
throughout
time
cours
dontreat
mice
tunelposit
cell
hippocampu
correspond
limit
immun
cell
infiltr
immun
system
primari
mediat
neuron
damag
fatal
alphaviru
encephalomyel
mice
lack
variou
compon
cellular
immun
infect
nsv
mortal
significantli
decreas
indic
import
role
cell
rowel
griffin
furthermor
nsvinduc
clinic
diseas
develop
mortal
coincid
infiltr
cell
brain
kulcsar
et
al
studi
neuron
loss
necrosi
hippocampu
lumbar
spinal
cord
correspond
peak
inflamm
period
treatment
mous
brain
fewer
patholog
chang
fewer
tunelposit
cell
previous
shown
neuron
compar
sinvinfect
untreat
mice
due
limit
abil
neuron
regener
clearanc
virus
infect
requir
noncytolyt
process
avoid
longterm
neurolog
deficit
griffin
innat
product
type
ifn
particularli
help
earli
control
sinv
replic
spread
adapt
immun
respons
respons
viru
clearanc
burdeinickkerr
et
al
byrn
et
al
sinv
clearanc
cn
achiev
synergist
cooper
sinvspecif
antibodi
burdeinickkerr
et
al
impair
prolifer
b
cell
produc
antibodi
cell
produc
viru
clearanc
brain
spinal
cord
delay
period
treatment
howev
treatment
stop
level
sinvspecif
igm
igg
increas
serum
mrna
express
protein
product
increas
brain
sinvspecif
igm
igg
detect
low
dose
dontreat
mous
brain
dpi
igm
detect
serum
low
high
dose
dontreat
mice
dpi
high
level
dpi
support
hypothesi
primari
effect
immun
system
occur
peripheri
rather
cn
mous
model
chang
brain
level
differ
treatment
group
time
close
follow
mononuclear
cell
number
fig
h
e
inflamm
score
fig
peak
level
preced
peak
infiltr
cell
two
four
day
fig
c
quickli
appear
treatment
stop
macrophag
sometim
sourc
darwich
et
al
natur
killer
nk
cell
like
nont
cell
sourc
situat
trinchieri
et
al
nk
cell
quickli
activ
produc
sun
lanier
prolifer
respons
viru
infect
biron
et
al
dokun
et
al
sun
et
al
lopezverg
et
al
howev
metabol
requir
nk
cell
prolifer
extens
studi
gardin
finlay
requir
glutamin
may
less
cell
therefor
specul
nk
cell
account
earli
increas
ifng
mrna
protein
brain
dontreat
mice
contribut
increas
untreat
infect
mice
fig
f
investig
question
requir
anoth
secondari
consequ
viru
infect
contribut
neuron
damag
death
glutam
excitotox
glutam
major
excitatori
neurotransmitt
bind
glutam
receptor
recipi
neuron
sattler
tymianski
result
influx
excess
calcium
postsynapt
neuron
turn
trigger
cascad
result
free
radic
product
mitochondri
dysfunct
ultim
cell
death
j
lee
et
al
nicotera
orreniu
hippocamp
neuron
brain
motor
neuron
spinal
cord
especi
sensit
glutam
excitotox
carriedo
et
al
nadler
et
al
olney
et
al
rothstein
et
al
process
play
role
sinvinduc
patholog
darman
et
al
nargiaizenman
et
al
furthermor
treatment
ampa
receptor
antagonist
protect
mice
nsvinduc
death
nargiaizenman
et
al
green
et
al
examin
effect
treatment
glutam
excitotox
examin
express
sever
indirect
marker
excitotox
express
gfap
astrocyt
protein
upregul
respons
neuron
damag
local
cytokin
product
affect
treatment
consist
induct
innat
respons
sinv
infect
primarili
express
astrocyt
also
found
microglia
respons
major
glutam
uptak
synapt
cleft
thu
import
player
prevent
excitotox
danbolt
sever
cn
viru
infect
includ
nsv
human
coronaviru
hcov
human
tlymphotrop
viru
human
cytomegaloviru
downregul
express
akaoka
et
al
brison
et
al
darman
et
al
irani
zhang
et
al
other
includ
herp
simplex
viru
japanes
enceph
viru
infect
induc
upregul
mishra
et
al
mishra
et
al
persson
et
al
studi
sinv
infect
reduc
express
brain
determin
ihc
immunoblot
dpi
compar
mockinfect
control
mice
howev
treatment
inconsist
restor
express
brain
dpi
compar
express
gfap
compar
untreat
sinvinfect
mice
microglia
also
sourc
glutam
takeuchi
suzumura
microgli
activ
contribut
excitotox
infect
sever
virus
includ
hcov
hiv
siv
borna
diseas
viru
brison
et
al
jiang
et
al
koutsilieri
et
al
ovanesov
et
al
express
marker
activ
microglia
increas
untreat
sinvinfect
mous
brain
compar
uninfect
control
treatment
decreas
express
dpi
howev
macrophag
also
express
infiltr
brain
nsv
infect
kulcsar
et
al
kulcsar
et
al
cell
could
also
contribut
increas
express
sinv
infect
studi
directli
measur
glutam
evalu
excitotox
difficult
perform
vivo
would
help
elucid
role
glutamin
antagonist
play
prevent
excitotox
inabl
effect
cross
blood
brain
barrier
vk
baxter
et
al
virolog
bbb
could
explain
inconsist
effect
drug
administr
glutam
excitotox
potter
et
al
sinv
infect
approxim
mice
treat
develop
clinic
sign
encephalomyel
dpi
compar
almost
untreat
sinvinfect
mice
immun
respons
almost
complet
absent
cn
period
treatment
suggest
anoth
mechan
glutam
excitotox
contribut
clinic
diseas
develop
therefor
conclud
treatment
suppress
immun
cell
prolifer
peripheri
lead
decreas
cell
death
delay
viru
clearanc
cn
like
less
effect
glutam
excitotox
due
poor
abil
cross
bbb
result
residu
clinic
diseas
develop
howev
prodrug
version
contain
methylpom
amin
isopropyl
ester
carboxyl
achiev
tenfold
higher
cerebrospin
fluid
plasma
ratio
compar
parent
rhesu
macaqu
recent
develop
rai
et
al
treatment
alphaviru
encephalomyel
current
limit
support
care
usual
initi
clinic
diseas
develop
glutamin
antagonist
provid
attract
potenti
therapi
effect
sever
tumor
magil
et
al
rai
et
al
shelton
et
al
sullivan
et
al
immun
suppress
properti
prevent
allograft
reject
attenu
clinic
sign
associ
experiment
autoimmun
encephalomyel
plasmodium
infect
gordon
et
al
lee
et
al
plaima
et
al
shiji
et
al
howev
gastrointestin
toxic
observ
mice
rai
et
al
human
trial
earhart
et
al
earhart
et
al
sklaroff
et
al
limit
use
therapeut
agent
prodrug
reduc
toxic
develop
regardless
immun
system
play
role
cn
patholog
viru
clearanc
thought
consider
employ
evalu
drug
suppress
immun
system
potenti
therapeut
alphaviru
encephalomyel
